High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases

Cancer Genetics and Cytogenetics

Volumn 197, Issue 1, 2010, Pages 91-94

  Moiseyenko, Vladimir M ^a,b   Protsenko, Svetlana A ^a   Brezhnev, Nikita V ^a   Maximov, Sergey Ya ^a   Gershveld, Eduard D ^a   Hudyakova, Marina A ^a   Lobeiko, Oksana S ^a   Gergova, Madina M ^a   Krzhivitskiy, Pavel I ^a   Semionov, Igor I ^a   Matsko, Dmitry E ^a   Iyevleva, Aglaya G ^a,c   Sokolenko, Anna P ^a,c   Sherina, Nathalia Yu ^a   Kuligina, Ekatherina Sh ^a   Suspitsin, Evgeny N ^a   Togo, Alexandr V ^a   Imyanitov, Evgeny N ^a,b,c  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b St Petersburg Medical Academy for Postgraduate Studies   (Russian Federation)

^c SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CA 125 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; LETROZOLE; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; ANAMNESIS; CANCER CHEMOTHERAPY; CASE REPORT; DRUG EFFICACY; DRUG SENSITIVITY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LETTER; LUNG METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CISPLATIN; FEMALE; GENES, BRCA1; HUMANS; MIDDLE AGED;

EID: 74749092179     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.10.003     Document Type: Letter

References (11)

1. Byrski T., Huzarski T., Dent R., Gronwald J., Zuziak D., Cybulski C., Kladny J., Gorski B., Lubinski J., and Narod S.A. Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 115 (2009) 359-363
2. Sokolenko A.P., Rozanov M.E., Mitiushkina N.V., Sherina N.Y., Iyevleva A.G., Chekmariova E.V., Buslov K.G., Shilov E.S., Togo A.V., Bit-Sava E.M., Voskresenskiy D.A., Chagunava O.L., Devilee P., Cornelisse C., Semiglazov V.F., and Imyanitov E.N. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer 6 (2007) 281-286
3. Rhiem K., Wappenschmidt B., Bosse K., Köppler H., Tutt A.N., and Schmutzler R.K. Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer. Clin Oncol (R Coll Radiol) 21 (2009) 448-450
4. Huang F., Kushner Y.B., Langleben A., and Foulkes W.D. Medscape. Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer. Nat Rev Clin Oncol 6 (2009) 488-492
5. Moule R., Sohaib A., and Eeles R. Dramatic response to platinum in a patient with cancer with a germline BRCA2 mutation. Clin Oncol (R Coll Radiol) 21 (2009) 444-447
6. Tan D.S., Rothermundt C., Thomas K., Bancroft E., Eeles R., Shanley S., Ardern-Jones A., Norman A., Kaye S.B., and Gore M.E. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 26 (2008) 5530-5536
7. Stewart D.J., and Kurzrock R. Cancer: the road to Amiens. J Clin Oncol 27 (2009) 328-333
8. Swisher E.M., Sakai W., Karlan B.Y., Wurz K., Urban N., and Taniguchi T. Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance. Cancer Res 68 (2008) 2581-2586
9. Byrski T., Gronwald J., Huzarski T., Grzybowska E., Budryk M., Stawicka M., Mierzwa T., Szwiec M., Wiśniowski R., Siolek M., Narod S.A., and Lubinski J. Polish Hereditary Breast Cancer Consortium. Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. Breast Cancer Res Treat 108 (2008) 289-296
10. Wysocki P.J., Korski K., Lamperska K., Zaluski J., and Mackiewicz A. Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations. Med Sci Monit 14 (2008) SC7-10
11. Hosey A.M., Gorski J.J., Murray M.M., Quinn J.E., Chung W.Y., Stewart G.E., James C.R., Farragher S.M., Mulligan J.M., Scott A.N., Dervan P.A., Johnston P.G., Couch F.J., Daly P.A., Kay E., McCann A., Mullan P.B., and Harkin D.P. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99 (2007) 1683-1694